IP Library Granted Patent US 8,663,166
Granted Patent B2
US 8,663,166 · App. 12/796,203 · Granted Mar 4, 2014

Powerhead control in a power injection system

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,663,166
App. No.
12/796,203
Granted
Mar 4, 2014
Kind
B2
Abstract

A dual head contrast media injection system performs a patency check or test injection, determining flow rate and/or flow volume from the programmed protocol. The tubing that connects syringes to a patient shares only a short common section near to the patient. Appropriate injection steps are taken to compensate for tubing elasticity. A wireless remote control and a touch screen control are provided, improving functionality and information delivery. The display brightness is controlled based on the ambient light, and the display panel includes a double swivel permitting re-orientation. The orientation of the display may also be controlled based on, e.g., the current step, the tilt angle of the powerhead, or a manual control. Furthermore, the display is customizable to identify the type of fluid (contrast, saline, etc.) on either side of the injector, to provide matched color coding, and to provide a folder/tab analogy for retrieving injection protocol parameters.

Claims (38)

1. A medical fluid injector system comprising:

a stand;

a powerhead comprising a powerhead housing, wherein said powerhead is interconnected with, supported by, and tiltable relative to said stand;

a syringe mounted to said powerhead housing and having a movable plunger disposed within said syringe, wherein at least a portion of said syringe is located outside said powerhead housing;

a motorized drive having a syringe ram designed both to move in and out of said powerhead housing to cause movement of said plunger within the syringe; and

a touch screen display incorporated into said powerhead housing and configured to provide an interactive user interface for controlling the system, wherein a first screen presentable on said touch screen display comprises a button, wherein pressing said button alters an orientation of an output on said first screen, and wherein said first screen further comprises:

a first volume region for a first phase of an injection procedure;

a first flow rate region for said first phase of said injection procedure;

a second volume region for a second phase of said injection procedure; and

a second flow rate region for said second phase of said injection procedure, wherein pressing any of said first volume region, said first flow rate region, said second volume region, and said second flow rate region on said first screen generates a second screen, wherein said second screen comprises a protocol parameter entry screen, wherein said protocol parameter entry screen comprises a separate input region for each of a volume for said first phase, a flow rate for said first phase, a volume for said second phase, and a flow rate for said second phase, wherein each said input region may be pressed to add a value to the corresponding said input region.

2. The system of claim 1 , wherein said interactive user interface provides a series of display screens having a plurality of input regions.

3. The system of claim 2 , wherein said interactive user interface provides contextual help information for one or more of said display screens.

4. The system of claim 2 , wherein a brightness level of said touch screen display is dependent upon ambient light conditions.

5. The system of claim 1 , wherein said interactive user interface duplicates functionality of a console of the system.

6. The system of claim 1 , wherein said interactive user interface provides a redundant source for functionality of a console of the system.

7. The system of claim 1 , wherein said interactive user interface provides for entering a protocol.

8. The system of claim 1 , further comprising:

a swivel that allows said touch screen display to pivot relative to said powerhead housing.

9. The system of claim 1 , wherein said syringe ram of said drive motor is engaged with said plunger of said syringe.

10. The system of claim 9 , wherein at least a portion of said syringe ram of said drive motor is located within a barrel of said syringe in which said plunger is located.

11. The system of claim 1 , further comprising another syringe mounted to said powerhead housing and having a movable plunger disposed therein, wherein at least a portion of said another syringe is located outside said powerhead housing.

12. The system of claim 11 , further comprising another syringe ram designed both to move in and out of said powerhead housing to cause movement of said plunger of said another syringe within said another syringe.

13. The system of claim 11 , further comprising contrast media disposed within said syringe and saline disposed within said another syringe.

14. The system of claim 1 , wherein said interactive user interface provides for saving a protocol.

15. The system of claim 1 , wherein said interactive user interface provides for editing a protocol.

16. The system of claim 1 , wherein said interactive user interface provides for identifying total patient volume.

17. The system of claim 1 , wherein said interactive user interface provides for displaying historical injection data.

18. The system of claim 1 , wherein said interactive user interface provides for displaying injection phase information.

19. The system of claim 1 , wherein said interactive user interface provides for displaying injection delay information.

20. The system of claim 1 , wherein the interactive user interface provides for selecting a language setting.

21. The system of claim 1 , wherein said interactive user interface provides for programming a flow rate.

22. The system of claim 1 , wherein said interactive user interface provides for editing a flow rate.

23. The system of claim 1 , wherein said interactive user interface provides for programming a plurality of phases of an injection protocol.

24. The system of claim 1 , wherein said interactive user interface provides for editing a plurality of phases of an injection protocol.

25. The system of claim 1 , wherein said button facilitates the use of the powerhead housing in multiple orientations.

26. The system of claim 1 , wherein pressing said button reverses said output on said first screen.

27. The system of claim 1 , further comprising:

a controller that is configured to present said output on said touch screen display in a scale that is dependent upon a current operation being executed by the injector.

Assignments (7)
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 032480, FRAME 0001 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: THERAKOS, INC.; MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.); MALLINCKRODT CARRIBEAN, INC.; MALLINCKRODT US POOL LLC; MNK 2011 LLC (F/K/A MALLINCKRODT INC.); LUDLOW LLC (F/K/A LUDLOW CORPORATION); CNS THERAPEUTICS, INC.; MALLINCKRODT ENTERPRISES HOLDINGS LLC (F/K/A MALLINCKRODT ENTERPRISES HOLDINGS, INC.); MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS LLC (F/K/A MALLINCKRODT BRAND PHARMACEUTICALS, INC.); MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC.; MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC (F/K/A VTESSE INC.); MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.); INFACARE PHARMACEUTICAL CORPORATION; ST SHARED SERVICES LLC; IKARIA THERAPEUTICS LLC; INO THERAPEUTICS LLC
Reel/Frame 065609/0322 →
RELEASE OF SECURITY INTEREST Recorded Nov 30, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: LIEBEL-FLARSHEIM COMPANY LLC
Reel/Frame 037172/0094 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 31, 2014
From: MALLINCKRODT LLC
To: LIEBEL-FLARSHEIM COMPANY LLC
Reel/Frame 034715/0531 →
SECURITY INTEREST Recorded Mar 19, 2014
From: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS INC.; MALLINCKRODT CARIBBEAN, INC.; MALLINCKRODT US POOL LLC; MALLINCKRODT INC.; LUDLOW CORPORATION; CNS THERAPEUTICS, INC.; ENTERPRISES HOLDINGS, INC.; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS, INC; MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC; MALLINCKRODT ENTERPRISES HOLDINGS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 032480/0001 →
CHANGE OF LEGAL ENTITY Recorded Aug 16, 2011
From: MALLINCKRODT INC.
To: MALLINCKRODT LLC
Reel/Frame 026754/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 23, 2010
From: SMALL, JAMES R.; BROOKS, DAVID M.; NEER, CHARLES S.; FAGO, FRANK M.; WAGNER, GARY S.; BORGEMENKE, ELAINE; LAFFERTY, SEAN
To: LIEBEL-FLARSHEIM COMPANY
Reel/Frame 025400/0113 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 23, 2010
From: LIEBEL-FLARSHEIM COMPANY
To: MALLINCKRODT INC.
Reel/Frame 025400/0141 →